Commercial Vaccines Do Not Confer Protection against Two Genogroups of <i>Piscirickettsia salmonis</i>, LF-89 and EM-90, in Atlantic Salmon
In Atlantic salmon, vaccines have failed to control and prevent <i>Piscirickettsiosis</i>, for reasons that remain elusive. In this study, we report the efficacy of two commercial vaccines developed with the <i>Piscirickettsia salmonis</i> isolates AL100005 and AL 20542 again...
Main Authors: | Carolina Figueroa, Débora Torrealba, Byron Morales-Lange, Luis Mercado, Brian Dixon, Pablo Conejeros, Gabriela Silva, Carlos Soto, José A. Gallardo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/11/7/993 |
Similar Items
-
Complete Lipopolysaccharide of Piscirickettsia salmonis Is Required for Full Virulence in the Intraperitoneally Challenged Atlantic Salmon, Salmo salar, Model
by: Valeska Herrera, et al.
Published: (2022-03-01) -
Non-lysosomal Activation in Macrophages of Atlantic Salmon (Salmo salar) After Infection With Piscirickettsia salmonis
by: Diego Pérez-Stuardo, et al.
Published: (2019-03-01) -
Cohabitation of Piscirickettsia salmonis genogroups (LF-89 and EM-90): synergistic effect on growth dynamics
by: Gabriela Carril, et al.
Published: (2023-10-01) -
Why Does Piscirickettsia salmonis Break the Immunological Paradigm in Farmed Salmon? Biological Context to Understand the Relative Control of Piscirickettsiosis
by: Marco Rozas-Serri
Published: (2022-03-01) -
Exploring Sea Lice Vaccines against Early Stages of Infestation in Atlantic Salmon (<i>Salmo salar</i>)
by: Antonio Casuso, et al.
Published: (2022-07-01)